Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Other Non-Current Assets (2024 - 2026)

Carlsmed filings provide 2 years of Other Non-Current Assets readings, the most recent being $134000.0 for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 34.0% to $134000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $134000.0, a 34.0% increase, with the full-year FY2025 number at $134000.0, up 34.0% from a year prior.
  • Other Non-Current Assets hit $134000.0 in Q4 2025 for Carlsmed, down from $225000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $4.0 million in Q2 2025 to a low of $100000.0 in Q2 2024.